Regional Health Properties (RHEP) AI Stock Analysis

Top Page

Regional Health Properties

(Other OTC:RHEP)

Select Model

Rating:54Neutral

Price Target:$1.00▼(-4.76% Downside)

Action:reiterated

Date:08/17/26

The score is held back mainly by weak cash flow and soft technical momentum, even though recent profitability improved and valuation is very low. The balance sheet has improved, but the recovery still looks fragile.

Positive Factors

Revenue Growth and Earnings TurnaroundThe return to positive net income alongside roughly 21% TTM revenue growth indicates improved operating scale and tenant-related revenue performance, providing a stronger foundation for earnings over the next several months if growth persists.

Negative Factors

Negative Operating and Free Cash FlowNegative cash generation despite positive net income suggests earnings are not converting into liquidity. Continued shortfalls could increase reliance on financing or asset actions and constrain investment, maintenance, and tenant-support flexibility.

Regional Health Properties (RHEP) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $4.12M
Dividend Yield: ―
Average Volume (3M): 2,268
Price to Earnings (P/E): 0.5
Beta (1Y): 1.33
Revenue Growth: 199.28%
EPS Growth: ―
Country: US
Employees: 731
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Care Facilities

Regional Health Properties Business Overview & Revenue Model

Company Description

Regional Health Properties, Inc. (RHEP) functions as an independently managed real estate investment company, operating through its subsidiaries. Its core investment strategy centers on properties specifically developed for long-term care and senior...

How the Company Makes Money

RHEP primarily generates revenue by leasing its healthcare real estate to third-party operators. Its key revenue stream is rental income collected under lease agreements (typically long-term leases) where tenants operate the facilities and pay contra...

Regional Health Properties Financial Statement Overview

Summary

Recent revenue growth and a return to profitability are positive, but thin margins, negative TTM operating and free cash flow, and a history of volatile leverage keep the financial profile high risk.

Income Statement

62Positive

Balance Sheet

45Neutral

Cash Flow

38Negative

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Dec 2022	Dec 2021
Income Statement
Total Revenue	81.52M	53.16M	18.34M	17.16M	35.92M	26.69M
Gross Profit	20.52M	14.61M	8.30M	8.00M	9.98M	10.31M
EBITDA	9.58M	8.10M	2.22M	1.12M	-1.93M	4.08M
Net Income	4.07M	3.37M	-3.22M	-3.89M	-6.87M	-1.18M
Balance Sheet
Total Assets	67.96M	68.55M	60.47M	62.18M	68.58M	105.70M
Cash, Cash Equivalents and Short-Term Investments	1.73M	3,013	582.00K	953.00K	843.00K	6.79M
Total Debt	41.77M	42.48M	43.96M	45.68M	55.40M	84.94M
Total Liabilities	64.98M	63.51M	63.38M	62.00M	64.86M	95.30M
Stockholders Equity	2.98M	5.04M	-2.92M	185.00K	3.72M	10.40M
Cash Flow
Free Cash Flow	-3.94M	-3,129	1.41M	2.75M	-3.88M	4.77M
Operating Cash Flow	-2.57M	-2,260	1.94M	3.71M	-3.60M	4.89M
Investing Cash Flow	14.60M	15.10M	-530.00K	-958.00K	-281.00K	-123.00K
Financing Cash Flow	-10.66M	-10.25M	-2.13M	-2.48M	-2.06M	-2.42M

Regional Health Properties Technical Analysis

Technical Analysis SentimentPositive

Last Price1.05

Price Trends

50DMA1.04Positive

100DMA1.05Negative

200DMA1.18Negative

Market Momentum

MACD-0.00Positive

RSI52.87Neutral

STOCH63.29Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RHEP, the sentiment is Positive. The current price of 1.05 is above the 20-day moving average (MA) of 1.04, above the 50-day MA of 1.04, and below the 200-day MA of 1.18, indicating a neutral trend. The MACD of -0.00 indicates Positive momentum. The RSI at 52.87 is Neutral, neither overbought nor oversold. The STOCH value of 63.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RHEP.

Regional Health Properties Risk Analysis

Regional Health Properties disclosed 39 risk factors in its most recent earnings report. Regional Health Properties reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Regional Health Properties Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

RHEP against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NHC	85Outperform	$3.23B	22.83	12.94%	1.27%	7.19%	32.91%
PNTG	60Neutral	$1.46B	44.32	9.51%	―	37.90%	15.84%
RHEP	54Neutral	$4.12M	0.47	109.23%	―	199.28%	―
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SNDA	50Neutral	$1.65B	-5.54	-26.06%	―	49.37%	-171.65%
BKD	47Neutral	$2.48B	-17.95	405.63%	―	-4.42%	44.67%
CYH	39Underperform	$338.46M	-0.62	36.02%	―	-7.84%	-88.93%

* Healthcare Sector Average

Performance Comparison

RHEP and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
RHEP	Regional Health Properties, Inc.	1.05	-0.17	-13.93%
BKD	Brookdale Senior Living Inc.	10.39	1.22	13.30%
SNDA	Sonida Senior Living, Inc.	34.30	8.68	33.88%
CYH	Community Health Systems	2.40	-1.45	-37.66%
NHC	National Healthcare	206.14	86.88	72.85%
PNTG	Pennant Group Inc	41.66	16.61	66.31%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 17, 2026

Regional Health Properties AI Stock Analysis

Top Page